Joint press release by the NCT Heidelberg and the NCT/UCC Dresden
News
First set of standards developed for classification of somatic genetic variants in neoplasms
Under the leadership of scientists from the Department of Translational Medical Oncology at the...
DKFZ/NCT/DKTK-MASTER study: Molecular analysis supports therapy decisions in rare cancers
Joint press release of NCT Heidelberg and NCT/UCC Dresden
The EU-funded project CCE-DART (CCE Building Data Rich Clinical Trials) aims to...
“Molecular glue degraders” are a new class of cancer...
The prestigious European cancer association Cancer Core Europe (CCE) joint forces again...
The increasing number of biomarkers makes the decision for cancer treatment more...
One strategy to fight cancer is to target its Achilles' heel – the addiction to...
Chordomas are rare bone tumors for which only few options of treatment exist. Scientists and...
Resolution on molecular tumor boards (MTB)
The Directorate of NCT Heidelberg enacts guidelines for the organization of molecular tumor boards...